PTSD Trial, Recruiting NCT05457985 Sponsor: University of Michigan Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT05457985
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who receive care at a participating federally qualified health center (FQHC)
  • People who score 33 or higher on a standard PTSD symptom checklist called the PCL-5
  • People who own a mobile device (such as a smartphone or tablet) that can run the PTSD Coach app
  • People whose psychiatric medications (if any) have remained unchanged for at least 4 weeks

Who may not be able to join:

  • People with severe cognitive impairment that, in the investigators' judgment, would make it difficult to follow the study — for example, significant confusion or inability to follow a conversation or answer questions
  • People assessed as being at high risk of suicide, based on a specific screening tool used by the trial
  • People with a severe alcohol or drug use problem, based on scores from two standard screening tools (AUDIT score of 15 or higher, or a NIDA Quick Screen score of 27 or higher)
  • People experiencing active psychosis or bipolar disorder that is not currently being managed
  • People without stable housing
  • People who are currently receiving a trauma-focused therapy, such as Prolonged Exposure or Cognitive Processing Therapy
  • People who do not speak English (confirm with trial site for further details)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 734-647-6258

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
23 June 2022
Est. completion
31 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in PTSD symptoms as measured by the Clinician-Administered PTSD Scale for Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 (CAPS-5)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov